Sutro Biopharma, Inc. (STRO)
15.34
-0.14
(-0.90%)
USD |
NASDAQ |
Sep 18, 16:00
15.32
-0.02
(-0.13%)
After-Hours: 20:00
Sutro Biopharma Free Cash Flow : -145.62M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -145.62M |
| March 31, 2026 | -152.14M |
| December 31, 2025 | -178.93M |
| September 30, 2025 | -225.11M |
| June 30, 2025 | -252.02M |
| March 31, 2025 | -198.51M |
| December 31, 2024 | -194.64M |
| September 30, 2024 | -109.20M |
| June 30, 2024 | -77.69M |
| March 31, 2024 | -119.18M |
| December 31, 2023 | -115.93M |
| September 30, 2023 | -155.79M |
| June 30, 2023 | -56.85M |
| March 31, 2023 | -29.43M |
| Date | Value |
|---|---|
| December 31, 2022 | -4.309M |
| September 30, 2022 | -1.195M |
| June 30, 2022 | -95.71M |
| March 31, 2022 | -101.00M |
| December 31, 2021 | -97.00M |
| September 30, 2021 | -93.39M |
| June 30, 2021 | -84.65M |
| March 31, 2021 | -88.24M |
| December 31, 2020 | -74.93M |
| September 30, 2020 | -69.63M |
| June 30, 2020 | -65.76M |
| March 31, 2020 | -67.58M |
| December 31, 2019 | -68.50M |
| September 30, 2019 | -60.03M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Upstream Bio, Inc. | -136.46M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.29M |
| Cash from Investing (Quarterly) | 19.36M |
| Cash from Financing (Quarterly) | -0.418M |
| Free Cash Flow Per Share (Quarterly) | -2.311 |
| Free Cash Flow to Equity (Quarterly) | -45.40M |
| Free Cash Flow to Firm (Quarterly) | -28.43M |
| Free Cash Flow Yield | -81.26% |